Document:

Exhibit 4.1

 

FORM OF SHARE CERTIFICATE

 

Enzymotec Ltd.

 

	 	 	 
	Number 	 	Shares     
	 	 	 
	ENZY	 	CUSIP          
	 	 	 
	 	 	See Reverse for
	 	 	Certain
	 	 	Definitions

ENZYMOTEC LTD.

INCORPORATED UNDER THE LAWS OF THE STATE
OF ISRAEL

	 	 	 
	THIS CERTIFIES that	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	is the Registered Holder of 	 	 

 

FULLY PAID AND NON-ASSESSABLE ORDINARY

SHARES OF NIS 0.01 PAR VALUE EACH

of Enzymotec Ltd. transferable on the books of the Company
by the holder hereof in person or by duly authorized attorney only upon surrender of this Certificate properly endorsed or
with an appropriate instrument of transfer. This Certificate and the shares represented hereby are issued and shall be held
subject to all the provisions of the Articles of Association of the Company, as amended from time to time, to all of which
the holder by the acceptance hereof assents. This Certificate is not valid unless countersigned and registered by
the Transfer Agent and Registrar.

 

IN
WITNESS WHEREOF, the Company has caused this Certificate to be issued under the facsimile seal of the Company.

	 	 	 	 	 
	Dated: 	 	 	 	 
	 	 	 	 	 

 

	 	 	 	 	 	 	 
	Enzymotec Ltd.	 	 	 	 	 	 
	Corporate Seal 	 	ISRAEL	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	 	Director	 	Director

 

    	 

    	 

    

 

The following abbreviations, when used in the inscription
on the face of this Certificate, shall be construed as though they were written out in full according to applicable laws or regulations:

 

	TEN COM  	- 	as tenants in common	 	UNIF GIFT MIN ACT	 	 	 	Custodian	 	 
	 	 	 	 	 	 	(Cust)	 	 	 	(Minor)
	TEN ENT	-	as tenants by the entireties 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 
	JT TEN	-	as joint tenants with right	 	 	 	 	 	 	 	 
	 	 	of survivorship and not as	 	 	 	under Uniform Gifts to Minors
	 	 	tenants in common	 		 	Act	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 		 	(State)	 	 

Additional
abbreviations may also be used though not in the above list.

FOR VALUE RECEIVED,                     
HEREBY SELLS, ASSIGNS AND TRANSFERS UNTO

PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF
ASSIGNEE

 

PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS INCLUDING POSTAL
ZIP CODE OF ASSIGNEE

 

                                                            
SHARES REPRESENTED BY THE WITHIN CERTIFICATE, AND SO HEREBY IRREVOCABLY CONSTITUTES AND APPOINTS

 

ATTORNEY TO TRANSFER THE SAID SHARES ON THE BOOKS OF THE WITHIN-NAMED
CORPORATION AND FULL POWER OF SUBSTITUTION IN THE PREMISES.

	 	 	 	 	 	 	 
	DATED	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 
	 	 	 	 	 	 	NOTICE: THE SIGNATURE TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAME AS WRITTEN UPON THE FACE OF THE CERTIFICATE, IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT, OR ANY CHANGE, WHATSOEVER.
	 	 	 	 	 	 	 
	Signature(s) Guaranteed:	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	 	 
	THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM), PURSUANT TO S.E.C. RULE 17 Ad-15.Exhibit 10.1

 

English summary of a Lease Agreement, dated
September 17, 2009, by and between the Israeli Land Authority, as landlord (the "Landlord"), and Enzymotec Ltd.
(the "Company"), as tenant (the "Lease").

 

		·	Premises Covered by the Lease: Under the Lease, approximately 10,000 square meters (or 107,600
square feet) of land is leased (the "Premises"). The Premises is located in the Jezreel Valley Regional Council,
Israel.

 

		·	Permitted Use of Lease Premises: Industrial and manufacturing.

 

		·	Payment: NIS 1,800,000.00, paid in advance for the full duration of the lease.

 

		·	Terms of Lease: The term of the Lease is set retroactively from the day the transaction
was initially approved, May 9, 2007 and terminates on May 8, 2056. The Company was granted an option to extend the term of the
Lease for an additional period of 49 years from the date of termination of the initial Lease.

 

		·	Termination: The Landlord is entitled to terminate the Lease in the event that the Company
has not completed the construction of the facilities, on a scale of no less than 4,000 square meters on the Premises by the first
anniversary of the signing of the Lease, being September 17, 2010. The Company completed the building facilities by said date and
therefore the Landlord's termination option was cancelled.

 

		·	Modifications to the Premises: The Company may build facilities with a square meterage equal
to up to 70% of the Premises' square meterage in up to four stories above ground level (the "Built Area"). Of
the Built Area, 50% may be designated as the main activity area and the remaining 20% as ancillary services area. In addition the
Company may build underground parking under the Built Area without any meter age limitation.Exhibit 10.16

 

FORM OF INDEMNIFICATION AGREEMENT

 

THIS INDEMNIFICATION AGREEMENT (the “Agreement”),
dated as of [__________], 2013, is entered into by and between Enzymotec Ltd., an Israeli company whose address is Sagi 2000 Industrial
Area, Migdal Ha’Emeq 2310001, Israel (the “Company”), and [_______], the/a [insert position of the officer]
of the Company whose address is [__________] (the “Indemnitee”).

 

		WHEREAS,	Indemnitee is an Office Holder (“Nosei Misra”),
as such term is defined in the Companies Law, 5759–1999, as amended (the “Companies
Law” and “Office Holder” respectively),
of the Company; 

 

		WHEREAS,	both the Company and Indemnitee recognize the increased risk
of litigation and other claims being asserted against Office Holders of companies and that highly competent persons have become
more reluctant to serve corporations as directors and officers or in other capacities unless they are provided with adequate protection
through insurance or adequate indemnification against inordinate risks of claims and actions against them arising out of their
service to, and activities on behalf of, companies; 

 

		WHEREAS,	the Articles of Association
of the Company authorize the Company to indemnify and advance expenses to its Office Holders and provide for insurance and exculpation
to its Office Holders, in each case, to the fullest extent permitted by applicable law;

 

		WHEREAS,	the Company has determined that (i) the increased difficulty
in attracting and retaining competent persons is detrimental to the best interests of the Company’s shareholders and that
the Company should act to assure such persons that there will be increased certainty of such protection in the future, (ii) and
it is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, and to advance expenses
on behalf of, such persons to the fullest extent permitted by applicable law, so that they will serve or continue to serve the
Company free from undue concern that they will not be so indemnified; and

 

		WHEREAS,	in recognition of Indemnitee’s need for substantial protection
against personal liability in order to assure Indemnitee’s continued service to the Company in an effective manner and, in
part, in order to provide Indemnitee with specific contractual assurance that the indemnification, insurance and exculpation afforded
by the Articles of Association will be available to Indemnitee, the Company wishes to undertake in this Agreement for the indemnification
of and the advancing of expenses to Indemnitee to the fullest extent permitted by applicable law and as set forth in this Agreement
and provide for insurance and exculpation of Indemnitee as set forth in this Agreement.

 

NOW, THEREFORE, the parties hereto
agree as follows:

 

    	 

    	 

    

 

		1.	INDEMNIFICATION AND INSURANCE.

 

		1.1.	The Company hereby undertakes
                                                                    to indemnify Indemnitee to the fullest extent permitted by
                                                                    applicable law for any liability and expense specified in
                                                                    Sections ‎1.1.1
                                                                    through ‎1.1.4
                                                                    below, imposed on Indemnitee due to or in connection with
                                                                    an act performed by such Indemnitee, either prior to or after
                                                                    the date hereof, in Indemnitee’s capacity as an Office
                                                                    Holder, including, without limitation, as a director, officer,
                                                                    employee, agent or fiduciary of the Company, any subsidiary
                                                                    thereof or any another corporation, collaboration, partnership,
                                                                    joint venture, trust or other enterprise, in which Indemnitee
                                                                    serves at any time at the request of the Company (the “Corporate
                                                                    Capacity”). The term “act performed in Indemnitee’s
                                                                    capacity as an Office Holder” shall include, without
                                                                    limitation, any act, omission and failure to act and any other
                                                                    circumstances relating to or arising from Indemnitee’s
                                                                    service in a Corporate Capacity. Notwithstanding the foregoing,
                                                                    in the event that the Office Holder is the beneficiary of
                                                                    an indemnification undertaking provided by a subsidiary of
                                                                    the Company or any other entity [(other than a Secondary Indemnitor
                                                                    (as defined below))]1, with respect to his Corporate
                                                                    Capacity with such subsidiary or entity, then the indemnification
                                                                    obligations of the Company hereunder with respect to such
                                                                    Corporate Capacity shall only apply to the extent that the
                                                                    indemnification by such subsidiary or other entity does not
                                                                    actually fully cover the indemnifiable liabilities and expenses
                                                                    relating thereto. The following shall be hereinafter referred
                                                                    to as “Indemnifiable Events”:

 

		1.1.1.	Financial liability imposed on Indemnitee in favor of any person pursuant to a judgment, including
a judgment rendered in the context of a settlement or an arbitrator’s award approved by a court. For purposes of Section
‎1 of this Agreement, the term “person”
shall include, without limitation, a natural person, firm, partnership, joint venture, trust, company, corporation, limited liability
entity, unincorporated organization, estate, government, municipality, or any political, governmental, regulatory or similar agency
or body;

 

		1.1.2.	Reasonable Expenses (as defined below) expended or incurred by Indemnitee
as a result of (i) an investigation or any proceeding instituted against the Indemnitee by an authority that is authorized
to conduct an investigation or proceeding, and that was concluded without the filing of an indictment against the Indemnitee
and without imposing on the Indemnitee a financial obligation in lieu of a criminal proceeding,
or that was concluded without the filing of an indictment against the Indemnitee but imposing
a financial obligation in lieu of a criminal proceeding in an offence that does not require proof of mens rea, or (ii) in
connection with a financial sanction. In this section “conclusion of a proceeding without the filing of an indictment in
a matter in which a criminal investigation has been instigated” and “financial liability in lieu of a criminal proceeding”
shall have the meaning assigned to such terms under the Companies Law, and the term "financial sanction" shall mean such
term as referred to in Section 260(a)(1a) of the Companies Law;

  

 

1 Only relevant
to directors who have an additional indemnification agreement provided by their employees.

 

    	- 2 -

    	 

    

 

		1.1.3.	Reasonable Expenses incurred by or charged to Indemnitee by a court, in a proceeding instituted
against him by the Company or on its behalf or by another person, or in a criminal charge from which he was acquitted or in which
he was convicted of an offence that does not require proof of mens rea; and

 

		1.1.4.	Any other event, occurrence or circumstances in respect of which the Company may lawfully indemnify
an Office Holder of the Company (including, without limitation, indemnification with respect
to the matters referred to under Section 56h(b)(1) of the Israeli Securities Law 5728-1968, as amended (the "Securities
Law")).

 

For the purpose of this Agreement,
“Expenses” shall include, without limitation, attorneys’ fees and all other costs, expenses and obligations
paid or incurred by Indemnitee in connection with investigating, defending, being a witness in or participating in (including on
appeal), or preparing to defend, be a witness in or participate in any claim relating to any matter for which indemnification hereunder
may be provided. Expenses shall be considered paid or incurred by Indemnitee at such time as Indemnitee is required to pay or incur
such cost or expenses, including upon receipt of an invoice or payment demand. The Company shall pay the Expenses in accordance
with the provisions of Section ‎1.3.

 

		1.2.	Notwithstanding anything herein
                                                                    to the contrary, the Company shall indemnify the Indemnitee
                                                                    under Section ‎1.1.1
                                                                    only with respect to events described in Exhibit A
                                                                    hereto. The Board of Directors of the Company (the “Board”)
                                                                    has determined that the categories of events listed in Exhibit
                                                                    A are likely to occur in light of the operations of the Company.
                                                                    The maximum amount
                                                                    of indemnification
                                                                    payable by the Company under Section ‎1.1.1
                                                                    of this Agreement
                                                                    with respect to all persons with respect to whom the Company
                                                                    undertook to indemnify under agreements similar to this Agreement
                                                                    (the “Indemnifiable Persons”), for
                                                                    all events described in Exhibit A shall be as set forth in
                                                                    Exhibit A hereto (the “Limit Amount”).
                                                                    If the Limit Amount is insufficient to cover all the
                                                                    indemnity amounts payable with respect to all Indemnifiable
                                                                    Persons, then such amount shall be allocated to such Indemnifiable
                                                                    Persons pro rata according to the percentage of their
                                                                    culpability, as finally determined by a court in the relevant
                                                                    claim, or, absent such determination or in the event such
                                                                    persons are parties to different claims, based on an equal
                                                                    pro rata allocation among such Indemnifiable Persons.
                                                                    The Limit Amount payable by the Company as described in Exhibit
                                                                    A is deemed by
                                                                    the Company to be reasonable in light of the circumstances.
                                                                    The indemnification provided under Section ‎1.1.1
                                                                    herein shall not
                                                                    be subject to the limitations imposed by this Section ‎1.2
                                                                    and Exhibit A, if and to the extent, such limits are no
                                                                    longer required by the Companies Law.

 

    	- 3 -

    	 

    

 

		1.3.	If so requested by Indemnitee, and subject to the Company’s repayment and reimbursements
rights set forth in Sections ‎3 and ‎5
below, the Company shall pay amounts to cover Indemnitee’s Expenses with respect to which Indemnitee is entitled to be indemnified
under Section ‎1.1 above, as and when incurred. The payments
of such amounts shall be made by the Company directly to the Indemnitee’s legal and other advisors,
as soon as practicable, but in any event no later than fifteen (15) days after written demand by such Indemnitee therefor
to the Company, and any such payment shall be deemed to constitute indemnification hereunder. As part of the aforementioned undertaking,
the Company will make available to Indemnitee any security or guarantee that Indemnitee may be required to post in accordance with
an interim decision given by a court, governmental or administrative body, or an arbitrator, including for the purpose of substituting
liens imposed on Indemnitee’s assets.

 

		1.4.	The Company’s obligation to indemnify Indemnitee and advance Expenses in accordance with
this Agreement shall be for such period (the “Indemnification Period”) as Indemnitee shall be subject to any
actual, possible or threatened claim, action, suit, demand or proceeding or any inquiry or investigation, whether civil, criminal
or investigative, arising out of the Indemnitee’s service in the Corporate Capacity as described in Section ‎1.1
above, whether or not Indemnitee is still serving in such position.

 

		1.5.	The Company undertakes that, subject to the mandatory limitations under applicable law, as long
as it may be obligated to provide indemnification and advance Expenses under this Agreement, the Company will purchase and maintain
in effect directors and officers liability insurance, which will include coverage for the benefit of the Indemnitee, providing
coverage in amounts as reasonably determined by the Board (but in no event less than US$[25] million); [provided that, the Company
shall have no obligation to obtain or maintain directors and officers insurance policy if the Company determines in good faith
that such insurance is not reasonably available, the premium costs for such insurance are disproportionate to the amount of coverage
provided, or the coverage provided by such insurance is so limited by exclusions that it provides an insufficient benefit]. The
Company hereby undertakes to notify the Indemnitee 30 days prior to the expiration or termination of the directors and officers’
liability insurance. 

 

		1.6.	The Company undertakes to give prompt written notice of the commencement of any claim hereunder
to the insurers in accordance with the procedures set forth in each of the policies. The Company shall thereafter diligently take
all actions reasonably necessary under the circumstances to cause such insurers to pay, on behalf of Indemnitee, all amounts payable
as a result of such action, suit, proceeding, inquiry or investigation in accordance with the terms of such policies. The above
shall not derogate from Company’s authority to freely negotiate or reach any compromise with the insurer which is reasonable
in the Company’s sole discretion provided that the Company shall act in good faith and in a diligent manner.

  

    	- 4 -

    	 

    

 

		2.	SPECIFIC LIMITATIONS ON INDEMNIFICATION.

 

Notwithstanding anything to
the contrary in this Agreement, the Company shall not indemnify or advance Expenses to Indemnitee with respect to (i) any act,
event or circumstance with respect to which it is prohibited to do so under applicable law, or (ii) a counterclaim made by the
Company or in its name in connection with a claim against the Company filed by the Indemnitee.

 

		3.	REPAYMENT OF EXPENSES.

 

		3.1.	In the event that the Company provides or is required to provide indemnification with respect to
Expenses hereunder and at any time thereafter the Company determines, based on advice from its legal counsel, that the Indemnitee
was not entitled to such payments, the amounts so indemnified by the Company will be promptly repaid by Indemnitee, unless the
Indemnitee disputes the Company’s determination, in which case the Indemnitee’s obligation to repay to the Company
shall be postponed until such dispute is resolved.

 

		3.2.	Indemnitee’s obligation to repay to the Company for any Expenses or other sums paid hereunder
shall be deemed a loan given to Indemnitee by the Company subject to the minimum interest rate prescribed by Section 3(9) of the
Income Tax Ordinance [New Version], 1961, or any other legislation replacing it, which is not considered a taxable benefit.

 

		4.	SUBROGATION.

 

		4.1.	[Except as set forth in Section
                                                                    ‎4.2
                                                                    below,]2 In the event of payment under this Agreement,
                                                                    the Company shall be subrogated to the extent of such payment
                                                                    to all of the rights of recovery of Indemnitee, who shall
                                                                    execute all documents required and shall do everything that
                                                                    may be necessary to secure such rights, including the execution
                                                                    of such documents necessary to enable the Company effectively
                                                                    to bring suit to enforce such rights.

 

		4.2.	[The Company hereby acknowledges
                                                                    that Indemnitee has certain rights to indemnification, advancement
                                                                    of expenses and/or insurance provided by [venture capital
                                                                    fund] OR [shareholder(s) of the Company and certain of [its]/[their]
                                                                    affiliates] (collectively, the “Secondary Indemnitors”).
                                                                    The Company hereby agrees (i) that it is the indemnitor of
                                                                    first resort (i.e., its obligations to Indemnitee are primary
                                                                    and any obligation of the Secondary Indemnitors to advance
                                                                    expenses or to provide indemnification for the same expenses
                                                                    or liabilities incurred by Indemnitee are secondary), (ii)
                                                                    that it shall be required to advance the full amount of expenses
                                                                    incurred by Indemnitee and shall be liable for the full amount
                                                                    of all Expenses, judgments, penalties, fines and amounts paid
                                                                    in settlement to the extent legally permitted and as required
                                                                    by the terms of this Agreement and the Articles of Association
                                                                    of the Company (or any other agreement between the Company
                                                                    and Indemnitee), without regard to any rights Indemnitee may
                                                                    have against the Secondary Indemnitors, and, (iii) that it
                                                                    irrevocably waives, relinquishes and releases the Secondary
                                                                    Indemnitors from any and all claims against the Secondary
                                                                    Indemnitors for contribution, subrogation or any other recovery
                                                                    of any kind in respect thereof. The Company further agrees
                                                                    that no advancement or payment by the Secondary Indemnitors
                                                                    on behalf of Indemnitee with respect to any claim for which
                                                                    Indemnitee has sought indemnification from the Company shall
                                                                    affect the foregoing and the Secondary Indemnitors shall have
                                                                    a right of contribution and/or be subrogated to the extent
                                                                    of such advancement or payment to all of the rights of recovery
                                                                    of Indemnitee against the Company. The Company and Indemnitee
                                                                    agree that the Secondary Indemnitors are express third party
                                                                    beneficiaries of the terms of this Section ‎4.2.3

  

 

2 NTD: only
for those directors for whom this is applicable.

3 NTD: only for those directors
for whom this is applicable.

 

    	- 5 -

    	 

    

 

		5.	REIMBURSEMENT.

 

[Except as set forth in Section
‎4.2 above,] 4
The Company shall not be liable under this Agreement to make any payment in connection with any Indemnifiable Event to the extent
Indemnitee has otherwise actually received payment under any insurance policy or otherwise (without any obligation of Indemnitee
to repay any such amount) of the amounts otherwise indemnifiable hereunder. Any amounts paid to Indemnitee under such insurance
policy or otherwise after the Company has indemnified Indemnitee for such liability or Expense shall be repaid to the Company promptly
upon receipt by Indemnitee, in accordance with the terms set forth in Section ‎3.2.

 

		6.	EFFECTIVENESS.

 

This Agreement shall be valid,
binding and enforceable in accordance with its terms and shall be in full force and effect immediately upon its approval by the
Company’s general meeting of shareholders.5

 

		7.	NOTIFICATION AND DEFENSE OF CLAIM.

 

Indemnitee shall notify the
Company of the commencement of any action, suit or proceeding, and of the receipt of any notice or threat that any such legal proceeding
has been or shall or may be initiated against Indemnitee (including any proceedings by or against the Company and any subsidiary
thereof), promptly upon Indemnitee first becoming so aware; but the omission so to notify the Company will not relieve the Company
from any liability which it may have to Indemnitee under this Agreement unless and
to the extent that such failure to provide notice materially and adversely prejudices the Company’s ability to defend such
action. Notice to the Company shall be directed to the Chief Executive Officer or Chief Financial Officer of the Company
at the address shown in the preamble to this Agreement (or such other address as the Company shall designate in writing to Indemnitee).
With respect to any such action, suit or proceeding as to which Indemnitee notifies the Company of the commencement thereof and
without derogating from Sections ‎1.1 and ‎2:

 

		7.1.	The Company will be entitled to participate therein at its own expense.

 

 

4 NTD: only for those directors
for whom this is applicable.

5 NTD: If
already approved by SH replace with: "The Company represents and warrants that this Agreement is valid, binding and enforceable
in accordance with its terms and was duly adopted and approved by the Company, and shall be in full force and effect immediately
upon its execution". 

 

    	- 6 -

    	 

    

 

		7.2.	Except as otherwise provided below, the Company, alone or jointly with any other indemnifying party
similarly notified, will be entitled to assume the defense thereof, with counsel selected by the Company which counsel is reasonably
reputable with experience in the relevant field. Indemnitee shall have the right to employ his or her own counsel in such action,
suit or proceeding, but the fees and expenses of such counsel incurred after notice from the Company of its assumption of the defense
thereof shall be at the expense of Indemnitee, unless: (i) the employment of counsel by Indemnitee has been authorized in
writing by the Company; (ii) the Company shall have, in good faith, reasonably concluded that there may be a conflict of interest
between the Company and Indemnitee in the conduct of the defense of such action; or (iii) the Company has not in fact employed
counsel to assume the defense of such action, in which cases the reasonable fees and expenses of counsel shall be at the expense
of the Company. The Company shall not be entitled to assume the defense of any action, suit or proceeding brought by or on behalf
of the Company or as to which[the Company shall have reached the conclusion specified in (ii) above.

 

		7.3.	The Company shall not be liable to indemnify Indemnitee under this Agreement for any amounts or
expenses paid in connection with a settlement of any action, claim or otherwise, effected without the Company’s prior written
consent.

 

		7.4.	The Company shall have the right to conduct the defense as it sees fit in its sole discretion (provided
that the Company shall conduct the defense in good faith and in a diligent manner), including the right to settle or compromise
any claim or to consent to the entry of any judgment against Indemnitee without the consent of the Indemnitee, provided that, the
amount of such settlement, compromise or judgment does not exceed the Limit Amount (if applicable) and is fully indemnifiable pursuant
to this Agreement (subject to Section ‎1.2 of this Agreement)
and/or applicable law, and any such settlement, compromise or judgment does not impose any penalty or limitation on Indemnitee
without the Indemnitee’s prior written consent. The Indemnitee’s consent
shall not be required if the settlement includes a complete release of Indemnitee, does not contain any admission of wrong-doing
by Indemnitee, and includes monetary sanctions only as provided above. In the case of criminal proceedings the Company
and/or its legal counsel will not have the right to plead guilty or agree to a plea-bargain in the Indemnitee’s name without
the Indemnitee’s prior written consent. Neither the Company nor Indemnitee will unreasonably withhold or delay their consent
to any proposed settlement.

 

		7.5.	Indemnitee shall fully cooperate with the Company and shall give the Company all information and
access to documents, files and to his advisors and representatives as shall be within Indemnitee’s power, in every reasonable
way as may be required by the Company with respect to any claim which is the subject matter of this Agreement and in the defense
of other claims asserted against the Company (other than claims asserted by Indemnitee), provided that the Company shall cover
all expenses, costs and fees incidental thereto such that the Indemnitee will not be required to pay or bear such expenses, costs
and fees.

 

    	- 7 -

    	 

    

 

		8.	EXCULPATION.

 

Subject to the provisions of
the Companies Law, the Company hereby releases, in advance, the Indemnitee from liability to the Company for any damage that
arises from the breach of the Indemnitee’s duty of care to the Company (within the meaning of such terms under Sections
252 and 253 of the Companies Law), other than breach of the duty of care towards the Company in a distribution (as such term is
defined in the Companies Law).

 

		9.	NON-EXCLUSIVITY.

 

The rights of the Indemnitee
hereunder shall not be deemed exclusive of any other rights Indemnitee may have under the Company’s Articles of Association,
applicable law or otherwise, and to the extent that during the Indemnification Period the indemnification rights of the then serving
directors and officers are more favorable to such directors or officers than the indemnification rights provided under this Agreement
to Indemnitee, Indemnitee shall be entitled to the full benefits of such more favorable indemnification rights to the extent permitted
by law.

 

		10.	PARTIAL INDEMNIFICATION.

 

If Indemnitee is entitled under
any provision of this Agreement to indemnification by the Company for some or a portion of the expenses, judgments, fines or penalties
actually or reasonably incurred by Indemnitee in connection with any proceedings, but not, however, for the total amount thereof,
the Company shall nevertheless indemnify Indemnitee for the portion of such expenses, judgments, fines or penalties to which Indemnitee
is entitled under any provision of this Agreement. Subject to the provisions of Section ‎5
above, any amount received by Indemnitee (under any insurance policy or otherwise) shall not reduce the Limit Amount hereunder
and shall not derogate from the Company’s obligation to indemnify the Indemnitee in accordance with the provisions of this
Agreement up to the Limit Amount, as set forth in Section ‎1.2.

 

		11.	BINDING EFFECT.

 

This Agreement shall be binding
upon and inure to the benefit of and be enforceable by the parties hereto and their respective successors and permitted assigns.
In the event of a merger or consolidation of the Company or a transfer or disposition of all or substantially all of the business
or assets of the Company, the Indemnitee shall be entitled to the same indemnification and insurance provisions as the most favorable
indemnification and insurance provisions afforded to the then-serving Office Holders of the Company. In the event that in connection
with such transaction the Company purchases a directors and officers’ “tail” or “run-off” policy
for the benefit of its then serving Office Holders, then such policy shall cover Indemnitee and such coverage shall be deemed to
be in satisfaction of the insurance requirements under this Agreement. This Agreement shall continue in effect during the Indemnification
Period regardless of whether Indemnitee continues to serve in a Corporate Capacity.

 

Any amendment to the Companies
Law, the Securities Law or other applicable law adversely affecting the right of the Indemnitee to be indemnified, insured or
released pursuant hereto shall be prospective in effect, and shall not affect the Company’s obligation or ability to indemnify[or
insure the Indemnitee for any act or omission occurring prior to such amendment, unless otherwise provided by applicable law.

 

    	- 8 -

    	 

    

 

		12.	SEVERABILITY.

 

The provisions of this Agreement
shall be deemed severable and the invalidity or unenforceability of any provision shall not affect the validity or enforceability
of the other provisions hereof. If any provision of this Agreement, or the application thereof or any circumstance, is invalid
or unenforceable, (a) a suitable and equitable provision shall be substituted therefor in order to carry out, so far as may be
valid and enforceable, the intent and purpose of such invalid or unenforceable provision and (b) the remainder of this Agreement
and the application of such provision or circumstances shall not be affected by such invalidity or unenforceability, nor shall
such invalidity or unenforceability affect the validity or enforceability of such provision, or the application thereof, in any
other jurisdiction.

 

		13.	NOTICE.

 

All notices and other communications
pursuant to this Agreement shall be in writing and shall be deemed provided if delivered personally, telecopied, sent by electronic
facsimile, email, reputable overnight courier or mailed by registered or certified mail (return receipt requested), postage prepaid,
to the parties at the addresses shown in the preamble to this Agreement, or to such other address as the party to whom notice is
to be given may have furnished to the other party hereto in writing in accordance herewith. Any such notice or communication shall
be deemed to have been delivered and received (i) in the case of personal delivery, on the date of such delivery, (ii) in the case
of telecopier or an electronic facsimile or email, one business day after the date of transmission if confirmation of receipt is
received, (iii) in the case of a reputable overnight courier, three business days after deposit with such reputable overnight courier
service, and (iv) in the case of mailing, on the seventh business day following that on which the mail containing such communication
is posted.

 

		14.	GOVERNING LAW; JURISDICTION.

 

This Agreement shall be governed
by and construed and enforced in accordance with the laws of the State of Israel, without giving effect to the conflicts of law
provisions of those laws. The Company and Indemnitee each hereby irrevocably consent to the jurisdiction and venue of the courts
of Tel Aviv, Israel for all purposes in connection with any action or proceeding which arises out of or relates to this Agreement.

 

		15.	ENTIRE AGREEMENT AND TERMINATION.

 

This Agreement represents the
entire agreement between the parties and supersedes any other agreements, contracts or understandings between the parties, whether
written or oral, with respect to the subject matter of this Agreement.

 

		16.	NO MODIFICATION AND NO WAIVER.

 

No supplement, modification
or amendment, termination or cancellation of this Agreement shall be binding unless executed in writing by both of the parties
hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions
hereof (whether or not similar) nor shall such waiver constitute a continuing waiver. Any waiver shall be in writing. The Company
hereby undertakes not to amend its Articles of Association in a manner which will adversely affect the provisions of this Agreement.

 

    	- 9 -

    	 

    

 

		17.	ASSIGNMENTS; NO THIRD PARTY RIGHTS

 

Neither party hereto may assign
any of its rights or obligations hereunder except with the express prior written consent of the other party. Nothing herein shall
be deemed to create or imply an obligation for the benefit of a third party. Without limitation of the foregoing, nothing herein
shall be deemed to create any right of any insurer that provides directors and officers’ liability insurance, to claim, on
behalf of Indemnitee, any rights hereunder.

 

		18.	COUNTERPARTS

 

This Agreement may be executed
in any number of counterparts, each of which shall be deemed an original and enforceable against the parties actually executing
such counterpart, and all of which together shall constitute one and the same instrument; it being understood that parties need
not sign the same counterpart. The exchange of an executed Agreement (in counterparts or otherwise) by facsimile or by electronic
delivery in pdf format shall be sufficient to bind the parties to the terms and conditions of this Agreement, as an original.

  

[SIGNATURE PAGE TO FOLLOW]

 

    	- 10 -

    	 

    

 

IN WITNESS WHEREOF,
the parties, each acting under due and proper authority, have executed this Indemnification Agreement as of the date first mentioned
above, in one or more counterparts.

 

Enzymotec Ltd.

 

	By:	 	 
	Name and title:	 	 

 

[Indemnitee]

 

	Name:	 	 
	Signature:	 	 

  

    	- 11 -

    	 

    

 

EXHIBIT
A*

 

	 	 	CATEGORY OF INDEMNIFIABLE EVENT	 	
        LIMIT AMOUNT PER

        EACH SPECIFIC

        EVENT WITHIN THIS

        CATEGORY OF

        EVENTS

	 	 	 	 	 
	1.	 	Claims in connection with employment relationships with and/or by employees of the Company, and in connection with business relations between the Company and its employees, independent contractors, customers, suppliers and various service providers.	 	The greater of (a) twenty-five percent (25%) of the Company’s total shareholders’ equity according to the Company’s most recent financial statements as of the time of the actual payment of indemnification and (b) $25,000,000 (the “Maximum Amount”)
	 	 	 	 	 
	2.	 	Negotiations, execution, delivery and performance of agreements of any kind or nature, anti-competitive acts, acts of commercial wrongdoing, approval of corporate actions including the approval of the acts of the Company’s management, their guidance and their supervision, actions concerning the approval of transactions with Office Holders or shareholders, including controlling persons and claims of failure to exercise business judgment and a reasonable level of proficiency, expertise and care with respect to the Company’s business. 	 	The Maximum Amount
	 	 	 	 	 
	3.	 	Violation, infringement and other misuse of copyrights, patents, designs, trade secrets and any other intellectual property rights, breach of confidentiality obligations, acts in regard of invasion of privacy including with respect to databases, acts in connection with slander and defamation, and claims in connection with publishing or providing any information, including any filings with any governmental authorities, whether or not required under any applicable laws.	 	The Maximum Amount
	 	 	 	 	 
	4.	 	Liabilities related to the violation, infringement and other misuse of copyrights, patents, designs, trade secrets and any other intellectual property rights of the Company and/or any subsidiary and its protection, including the registration or assertion of rights to intellectual property and the defense of claims related to intellectual property. 	 	The Maximum Amount

 

    	- 12 -

    	 

    

 

	5.	 	Violations of securities laws of any jurisdiction, including without limitation, fraudulent disclosure claims, failure to comply with any securities authority or any stock exchange disclosure or other rules and any other claims relating to relationships with investors, debt holders, shareholders and the investment community; claims relating to or arising out of financing arrangements, any breach of financial covenants or other obligations towards lenders or debt holders of the Company, class actions, violations of laws requiring the Company to obtain regulatory and governmental licenses, permits and authorizations in any jurisdiction; actions taken in connection with the issuance of any type of securities of Company, including, without limitation, the grant of options to purchase any of the same.	 	The Maximum Amount
	 	 	 	 	 
	6.	 	Liabilities arising from the conduct of clinical trials and/or testing, development or manufacturing of products developed or services provided by the Company and/or any Subsidiary or in connection with the distribution, sale, marketing, license or use of such products or services, including without limitations in connection with professional liability and product liability claims.	 	The Maximum Amount
	 	 	 	 	 
	7.	 	The offering of securities by the Company to the public and/or to private investors or the offer by the Company to purchase securities from the public and/or from private investors or other holders pursuant to a prospectus, agreements, notices, reports, tenders and/or other proceedings.	 	The Maximum Amount
	 	 	 	 	 
	8.	 	Events in connection with change in ownership or in the structure of the Company, its reorganization, dissolution, or any decision concerning any of the foregoing, including but not limited to, merger, sale or acquisition of assets, division, change in capital. 	 	The Maximum Amount
	 	 	 	 	 
	9.	 	Any claim or demand made in connection with any transaction not in the ordinary course of business of the Company, including the sale, lease or purchase of any assets or business.	 	The Maximum Amount

 

    	- 13 -

    	 

    

 

	10.	 	Any claim or demand made by any third party suffering any personal injury and/or bodily injury or damage to business or personal property or any other type of damage through any act or omission attributed to the Company, or its employees, agents or other persons acting or allegedly acting on its behalf, including, without limitation, failure to make proper safety arrangements for the Company or its employees and liabilities arising from any accidental or continuous damage or harm to the Company’s employees, its contractors, its guests and visitors as a result of an accidental or continuous event, or employment conditions, permanent or temporary, in the Company’s offices.	 	The Maximum Amount
	 	 	 	 	 
	11.	 	Any claim or demand made directly or indirectly in connection with complete or partial failure, by the Company or its directors, officers and employees, to pay, report, keep applicable records or otherwise, of any foreign, federal, state, county, local, municipal or city taxes or other compulsory payments of any nature whatsoever, including, without limitation, income, sales, use, transfer, excise, value added, registration, severance, stamp, occupation, customs, duties, real property, personal property, capital stock, social security, unemployment, disability, payroll or employee withholding or other withholding, including any interest, penalty or addition thereto, whether disputed or not.	 	The Maximum Amount
	 	 	 	 	 
	12.	 	Any administrative, regulatory, judicial or civil actions orders, decrees, suits, demands, demand letters, directives, claims, liens, investigations, proceedings or notices of noncompliance or violation by any governmental entity or other person alleging potential responsibility or liability (including potential responsibility or liability for costs of enforcement investigation, cleanup, governmental response, removal or remediation, for natural resources damages, property damage, personal injuries or penalties or for contribution, indemnification, cost recovery, compensation or injunctive relief) arising out of, based on or related to (a) the presence of, release, spill, emission, leaning, dumping, pouring, deposit, disposal, discharge, leaching or migration into the environment (each a “Release”) or threatened Release of, or exposure to, any hazardous, toxic, explosive or radioactive substances, wastes or other pollutants, including petroleum or petroleum distillates, asbestos or asbestos-containing material, polychlorinated biphenyls (“PCBs”) or PCB-containing materials or equipment, radon gas, infectious or medical wastes and all other substances or wastes of any nature regulated pursuant to any environmental law, at any location, whether or not owned, operated, leased or managed by the Company or any of its subsidiaries, or (b) circumstances forming the basis of any violation of any environmental law or environmental permit, license, registration or other authorization required under applicable environmental law.	 	The Maximum Amount

 

    	- 14 -

    	 

    

 

	13.	 	Any administrative, regulatory or judicial actions, orders, decrees, suits, demands, demand letters, directives, claims, liens, investigations, proceedings or notices of noncompliance or violation by any governmental entity or other person alleging the failure to comply with any statute, law, ordinance, rule, regulation, order or decree of any governmental entity applicable to the Company or any of its businesses, assets or operations, or the terms and conditions of any operating certificate or licensing agreement.	 	The Maximum Amount
	 	 	 	 	 
	14.	 	Participation and/or non-participation at the Company’s Board meetings, bona fide
    expression of opinion and/or voting and/or abstention from voting at the Company’s Board meetings.	 	The Maximum Amount
	 	 	 	 	 
	15.	 	Review and approval of the Company’s financial statements, including any action, consent or approval related to or arising from the foregoing, including, without limitations, execution of certificates for the benefit of third parties related to the financial statements. 	 	The Maximum Amount
	 	 	 	 	 
	16.	 	All actions, consents and approvals relating to a distribution of dividends, in cash or otherwise.	 	The Maximum Amount
	 	 	 	 	 
	17.	 	Liabilities arising out of advertising, including misrepresentations regarding the Company's products and unlawful distribution of emails.	 	The Maximum Amount
	 	 	 	 	 
	 	 	Aggregate Limit Amount for all events together: The greater of (a) twenty-five percent (25%) of the Company’s total shareholders’ equity according to the Company’s most recent financial statements as of the time of the actual payment of indemnification and (b) $25,000,000	 	 

 

		*	Any reference in this Exhibit A to the Company shall include the Company and any entity in which
the Indemnitee serves in a Corporate Capacity.

 

    	- 15 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00220-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00220-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00220-of-00352.parquet"}]]